Research on LIPITOR
As the #1 prescribed cholesterol-lowering medication in the world,
over 26 million people in the United States have been prescribed
LIPITOR.1
LIPITOR has been studied in more than 400 ongoing and completed
studies. These studies include over 80,000 patients.2
-
A landmark study found that LIPITOR reduced the risk of heart
attack, stroke, certain kinds of heart surgeries, and chest pain in
patients with several common risk factors for heart disease*
-
Another landmark study found that LIPITOR significantly reduces
the risk of heart attack and stroke in patients with both type 2
diabetes and at least 1 other risk factor† for heart
disease
Three times more cardiologists surveyed would recommend LIPITOR to
their own family members over other cholesterol-lowering
medications‡
Ask your doctor today if LIPITOR is right for you.